Rikus Knegtering

1.1k total citations
19 papers, 749 citations indexed

About

Rikus Knegtering is a scholar working on Psychiatry and Mental health, Philosophy and Neurology. According to data from OpenAlex, Rikus Knegtering has authored 19 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 4 papers in Philosophy and 2 papers in Neurology. Recurrent topics in Rikus Knegtering's work include Schizophrenia research and treatment (12 papers), Psychosomatic Disorders and Their Treatments (4 papers) and Sexual function and dysfunction studies (4 papers). Rikus Knegtering is often cited by papers focused on Schizophrenia research and treatment (12 papers), Psychosomatic Disorders and Their Treatments (4 papers) and Sexual function and dysfunction studies (4 papers). Rikus Knegtering collaborates with scholars based in Netherlands and United Kingdom. Rikus Knegtering's co-authors include Robert J. van den Bosch, Durk Wiersma, Stynke Castelein, Richard Bruggeman, Marco P. Boks, André Alemán, Fokko Nienhuis, Sjoerd Sytema, Lex Wunderink and C. J. Slooff and has published in prestigious journals such as American Journal of Psychiatry, Psychiatry Research and Schizophrenia Research.

In The Last Decade

Rikus Knegtering

18 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rikus Knegtering Netherlands 10 589 177 148 109 87 19 749
René S. Kahn Netherlands 5 805 1.4× 180 1.0× 193 1.3× 96 0.9× 76 0.9× 8 1.1k
Javier Vázquez-Bourgón Spain 16 464 0.8× 142 0.8× 58 0.4× 99 0.9× 58 0.7× 77 793
Alexandra Roldán Spain 11 353 0.6× 90 0.5× 45 0.3× 211 1.9× 81 0.9× 24 652
Ching‐Jui Chang Taiwan 16 426 0.7× 157 0.9× 62 0.4× 171 1.6× 98 1.1× 26 877
Mihai Gheorghe Romania 4 802 1.4× 188 1.1× 219 1.5× 67 0.6× 67 0.8× 4 910
Alan Mendelowitz United States 12 903 1.5× 251 1.4× 282 1.9× 104 1.0× 69 0.8× 20 1.1k
Thomas Walch Austria 14 406 0.7× 102 0.6× 37 0.3× 138 1.3× 29 0.3× 15 781
G. Remington Canada 8 468 0.8× 90 0.5× 74 0.5× 91 0.8× 92 1.1× 8 712
B. Jabs Germany 15 204 0.3× 136 0.8× 37 0.3× 108 1.0× 109 1.3× 35 568
Parita Shah Canada 16 338 0.6× 102 0.6× 45 0.3× 247 2.3× 26 0.3× 38 762

Countries citing papers authored by Rikus Knegtering

Since Specialization
Citations

This map shows the geographic impact of Rikus Knegtering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikus Knegtering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikus Knegtering more than expected).

Fields of papers citing papers by Rikus Knegtering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikus Knegtering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikus Knegtering. The network helps show where Rikus Knegtering may publish in the future.

Co-authorship network of co-authors of Rikus Knegtering

This figure shows the co-authorship network connecting the top 25 collaborators of Rikus Knegtering. A scholar is included among the top collaborators of Rikus Knegtering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rikus Knegtering. Rikus Knegtering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Knegtering, Rikus, et al.. (2010). Repetitive Transcranial Magnetic Stimulation for Negative Symptoms of Schizophrenia. The Journal of Clinical Psychiatry. 71(4). 411–418. 103 indexed citations
3.
Bais, Leonie, et al.. (2010). BRAIN ASYMMETRY FOR EMOTIONAL PROSODY IN KLINEFELTER'S SYNDROME: CAUSAL RELATIONS INVESTIGATED WITH TMS. Schizophrenia Research. 117(2-3). 233–234. 1 indexed citations
4.
Wunderink, Lex, Fokko Nienhuis, Sjoerd Sytema, et al.. (2008). GUIDED DISCONTINUATION VERSUS MAINTENANCE TREATMENT IN REMITTED FIRST EPISODE PSYCHOSIS: RELAPSE RATES AND FUNCTIONAL OUTCOME. Schizophrenia Research. 102(1-3). 52–53. 9 indexed citations
5.
Wunderink, Lex, Fokko Nienhuis, Sjoerd Sytema, et al.. (2007). Guided Discontinuation Versus Maintenance Treatment in Remitted First-Episode Psychosis. The Journal of Clinical Psychiatry. 68(5). 654–661. 157 indexed citations
6.
Knegtering, Rikus, et al.. (2006). Niacin skin flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Research. 143(2-3). 303–306. 32 indexed citations
7.
Knegtering, Rikus, et al.. (2005). Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels. American Journal of Psychiatry. 162(5). 1010–1012. 123 indexed citations
8.
Knegtering, Rikus, et al.. (2005). Evaluation of the Subjects' Response to Antipsychotics Questionnaire. International Clinical Psychopharmacology. 21(1). 63–69. 32 indexed citations
9.
Knegtering, Rikus, et al.. (2004). The long-term effects of depot antipsychotics or clozapine on sexual functioning. Schizophrenia Research. 67(1). 181–181. 1 indexed citations
10.
Boks, Marco P., Peter F. Liddle, Johannes G. M. Burgerhof, Rikus Knegtering, & Robert J. van den Bosch. (2004). Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatrica Scandinavica. 110(1). 29–35. 72 indexed citations
11.
Knegtering, Rikus, et al.. (2004). A Randomized Open-Label Study of the Impact of Quetiapine Versus Risperidone on Sexual Functioning. Journal of Clinical Psychopharmacology. 24(1). 56–61. 114 indexed citations
12.
Boks, Marco P., et al.. (2003). Influence of antipsychotic agents on neurological soft signs and dyskinesia in first episode psychosis. Psychiatry Research. 119(1-2). 167–170. 18 indexed citations
13.
Knegtering, Rikus, et al.. (2003). The spectrum of subjective effects of antipsychotic medication. Acta Neuropsychiatrica. 15(5). 274–279. 6 indexed citations
14.
Knegtering, Rikus. (2003). Antipsychotic treatment and sexual functioning. 1 indexed citations
15.
Wiersma, Durk, et al.. (2002). Does cognition predict outcome and course of illness in schizophrenia. Schizophrenia Research. 53(3). 127–127. 2 indexed citations
16.
Knegtering, Rikus, et al.. (2001). Sexual dysfunctions in patients using risperidone or olanzapine: A randomised trial. Data Archiving and Networked Services (DANS). 1 indexed citations
17.
Knegtering, Rikus, et al.. (2001). Compensation of neurocognitive deficits: Influence on course of illness in schizophrenia. Data Archiving and Networked Services (DANS). 1 indexed citations
18.
Boks, Marco P., Sascha Russo, Rikus Knegtering, & Robert J. van den Bosch. (2000). The specificity of neurological signs in schizophrenia: a review. Schizophrenia Research. 43(2-3). 109–116. 73 indexed citations
19.
Wiersma, D., et al.. (2000). Do schizophrenic patients without neuropsychological deficits still show signs of cognitive decline?. Schizophrenia Research. 41(1). 269–269. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by René S. Kahn Breakdown of academic impact, for papers by Javier Vázquez-Bourgón Breakdown of academic impact, for papers by Alexandra Roldán Breakdown of academic impact, for papers by Ching‐Jui Chang Breakdown of academic impact, for papers by Mihai Gheorghe Breakdown of academic impact, for papers by Alan Mendelowitz Breakdown of academic impact, for papers by Thomas Walch Breakdown of academic impact, for papers by G. Remington Breakdown of academic impact, for papers by B. Jabs Breakdown of academic impact, for papers by Parita Shah
Rankless by CCL
2026